MCW Pancreatic Cancer Translational Science Forum

Milwaukee, WI US
October 25, 2019

Pancreatic cancer is increasing in incidence and will become the second leading cause of cancer-related deaths by 2020. Researchers have moved an important step closer to understanding why pancreatic cancer is so hard to treat. With a median survival of only 6 months and a 5-year survival rate of about 8%, patients tend to be diagnosed when the disease has already spread to other parts of the body -- this is one part of the problem. Another is that when treated with existing chemotherapy drugs, patients tend to benefit only slightly or not at all.

This is the first meeting concentrating on preclinical and translational research.  The goal is to disseminate new scientific information while promoting collaboration between institutions that are performing research on pancreatic cancer.

Target Audience

Target audience includes clinicians, basic and translational scientists and population health scientists.

Learning Objectives

  • Provide a current update on the genetic evolution of pancreatic cancer.
  • Discuss evolving understanding of how Ras signaling affects the progression of pancreatic cancer
  • Identify important immunologic targets in the tumor microenvironment
  • Provide an update on current phase I clinical trials for pancreatic cancer
Additional information

Contact

Name: 
Heidi Brittnacher
Phone Number: 
+1 (414) 955-1831
Email: 
hbrittna@mcw.edu
Course summary
Available credit: 
  • 7.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 7.25 Hours of Participation
    Hours of Participation credit.
Course opens: 
07/24/2019
Course expires: 
01/17/2020
Event starts: 
10/25/2019 - 9:00am CDT
Event ends: 
10/25/2019 - 5:00pm CDT
Cost:
$1.00
Add to calendar: 
F&MCW Clinical Cancer Center
8800 West Doyne Avenue
Conference Room M
Milwaukee, WI 53226
United States

Parking Information: Parking will be available on-site. Due to construction on the MCW campus, updated parking instructions will be emailed to all attendees the week before the event.

Susan Tsai, MD, MHS

Associate Professor of Surgical Oncology 

Medical College of Wisconsin

 

Ben George, MD

Associate Professor of Medicine

Medical College of Wisconsin 

 

William Hall, MD

Associate Professor of Radiation Oncology

Medical College of Wisconsin

 

Douglas Evans, MD

Chair, Department of Surgery

Donald C. Ausman Family Foundation Professor of Surgery

Medical College of Wisconsin

 

Brian Haab, PhD

Professor of Cancer and Cell Biology

Assistant Dean, Van Andel Institute Graduate School

Lead Investigator, Van Andel Research Institue

Van Andel Institue
 

Erica Pratt, PhD, MS

Postdoctoral Research Fellow, Molecular Biochemistry

University of Minnesota

 

Raul Urrutia, MD

Professor of Surgery

Director, Genomic Sciences and Precision Center

Medical College of Wisconsin 

 

Lawrence Lum, MD, Sc.D

Professor of Medicine

Director, Development of GMP Facility

Director, Cellular Therapy

Scientific Director, BMT

University of Virginia

 

Matthew Riese, MD, PhD

Assistant Professor of Medicine

Associate Investigator, Blood Research Institute, BloodCenter of Wisconsin

Medical College of Wisconsin

 

Rupsa Datta, PhD 

Postdoctoral Research Associate

Morgridge Institute for Research 

Gwen Lomberk, PhD

Associate Professor of Surgery and Pharmacology & Toxicology

Chief, Division of Research

Director, Basic Science Research

Medical College of Wisconsin

 

Michael Dwinell, PhD

Professor and Founding Director, Center for Immunology

Director, Bobbie Nick Voss Laboratory for Colon Cancer Research

Leader, Molecular Cancer Therapeutics

Medical College of Wisconsin

 

In accordance with the ACCMEⓇ standard for Commercial Support Number 6, all in control of content have NO relevant financial relationships to disclose.

ACCME ACCREDITATION STATEMENT
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The Medical College of Wisconsin designates this live activity a maximum of  7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HOURS OF PARTICIPATION FOR ALLIED HEALTH PROFESSIONALS
The Medical College of Wisconsin designates this activity for up to 7.25 hours of participation for continuing education for allied health professionals.

Available Credit

  • 7.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 7.25 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$1.00
Please login or register to take this course.

This conference is complimentary, however registration is required; to register, please choose the appropriate options above.

Continuing Education Credits may be purchased for $25.00. If you wish to receive CE credit for this conference, choose the credit option and follow the prompts to check out. You will receive instructions on accessing your CE credits upon completion of the conference. If you do not wish to receive credit choose "No Credit".

Refund Policy: No refunds will be provided.

PLEASE NOTE! The billing address entered upon checkout must match the billing address on the credit card you will be using to pay for this course. MCW accepts MasterCard, VISA and Discover card.